期刊文献+

原发性胃肠道非霍奇金淋巴瘤预后因素分析 被引量:2

Prognosis analysis of 66 cases of primary gastrointestinalnon-Hodgkin′s lymphoma
下载PDF
导出
摘要 目的 :探讨原发性胃肠道非霍奇金淋巴瘤临床特征和生存率的关系。方法 :对 1980 - 1997年本院收治均经病理证实的 6 6例原发于胃肠道的非霍奇金淋巴瘤患者的临床资料进行回顾性分析。对患者年龄、性别、有无 B症状、确诊前病程、临床分期、病理类型、免疫分型、肿块大小、浸润深度、有无淋巴结和 (或 )脏器转移、骨髓浸润、原发部位、治疗措施等 13个变量进行单因素及 Cox多因素分析 ,并采用 Kaplan- Meier法及 L og- rank检验进行生存情况统计。结果 :单因素分析表明年龄、性别、确诊前病程、原发部位与预后无明显相关性 (P>0 .0 5 ) ;无 B症状组、临床分期为 E~ E期及 E~ 1 E期组、低中度恶性组、 B细胞型、肿瘤未突破浆膜层组、瘤体直径小于 10 cm组、无淋巴结和 (或 )脏器转移组、无骨髓浸润组、行手术 +化疗组 5年生存率预后均较佳(P<0 .0 5 ) ;Cox分析表明肿瘤直径 <10 cm与≥ 10 cm组、临床分期为 E~ E期与 E~ E期组、免疫分型为B细胞与 T细胞组及手术 +化疗与单纯手术组 5年生存率比较 ,差异均具有显著性 (P<0 .0 5 )。结论 :肿瘤大小、临床分期、免疫分型、治疗措施为影响原发性胃肠道非霍奇金淋巴瘤预后的重要因素。
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2004年第6期984-987,共4页 Journal of Jilin University:Medicine Edition
基金 长春市科委资助课题 (0 1- 0 86 5 10 )
  • 相关文献

参考文献9

  • 1Freeman MD, Berg JW, Culer S, et al. Occurrence and prognostic of extranodal lymphoma[J]. Cancer,1972,29(1):252.
  • 2Aozasa K,Tsujimoto M,Sakural M, et al.Non-Hodgkin's lymphoma in Osaka, Japan[J]. Eur J Cancer Clin Oncol,1985,21:487-492.
  • 3Dawson MP, Cornes JS, Morson BC. Primary malignant lymphoma tumors of the intestinal tract[J]. Br J Surg ,1961,40:80.
  • 4National Cancer Institute sponsored study of classifications of non-Hodgkin′s lymphomas: summary and description of a working formulation for clinical usage. The non-hodgkin′s lymphoma pathologic classification project[J]. Cancer,1982,49:2112-2135.
  • 5Kaplan EL,Meier P. Nonparametric estimation from incomplete observation[J]. J Am Statist Assoc,1958,53:457-481.
  • 6Cox DR.Regression models and life tables[J]. JR Stat Soc,1972,34(B):187-220.
  • 7Liangb R, Todd D.Chan TK,et al.Prognostic factors for primary gastrointestinal lymphoma[J]. Hematol Oncol,1995,13:153-163.
  • 8Bartlett DL, Karpeh MS, Filippa DA,et al. A Long-term follow-up after curative surgery for early gastric lymphoma[J]. Ann Surg,1996,1:53-62.
  • 9Sheridan P, Medley G, Brodie N.Gastrointestinal non-Hodgkin's lymphoma of the stomach: A prospective pilot study of surgery plus chemotherapy in early and advanced disease[J]. J Clin Oncol,1985,3:495-500.

同被引文献23

  • 1Farinha P,Randy D.Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma.J Clin Oncol,2005,23:6370-6378.
  • 2Baens M,Maes B,Steyls A,et al.The product of the t(11;18),an AP12-MLT fusion,marks nearly hall of gustrie MALT type lymphomas without large cell proliferation.Am J Pathol,2000,156:1433-1439.
  • 3Manson SD.Mucosa-associated lymphoid tisue(MALT)lymphoma.Semin Oncol Nurs,2006,22:73-79.
  • 4Kun SH,Chen LT,Yeh KH,et al.Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early stage,high-grade gastric mucosa-associated lymphoid tissue lymphomus.J Clin Oncol,2004,22:3491-2497.
  • 5Nagal S,Washiyama K,Kwrimoto M,et al.Aberrant nuclear factor-kappa B activity and its participation in the growth of human malignant astrocytoma.J Neurosurg,2002,96:909-917.
  • 6Yeh KH,Kuo SH,Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21).Blood,2005,106:1037-1041.
  • 7Lucas PC,Yonezumi M,Inohara N,et al.BCL10 and MALT1,independent targets of chromosomal translocation in MALT lymphoma,cooperate in novel NF-kB singling pathway.J Biol Chem,2001,276:19012-19019.
  • 8Jeffe ES,Harris NL,Dicbold J,et al.World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissue.a progress report.Am J Clin Pathol,1999,111(suppl 1):S8.
  • 9Waisberg J,Bromberg SH,Franco MIF,et al.The role of surgery in the treatment of primary gastric lymphoma.Int Surg,2000,85:219-225.
  • 10Charalambous GK,Gomatos IP,Konstudoulakis MM,et al.Protein expression of bax,bcl-2,and p53 in patients with non-Hodgkin's gastric lymphoma:prognostic significance.World J Surg,2000,24:608-614.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部